Get started
Author

Maurizio Puccetti

PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
2018 · Sara Bravaccini, Maurizio Puccetti, et al. · Scientific Reports · 190
PDF
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy
2015 · Paola Ulivi, Elisa Chiadini, et al. · Clinical Lung Cancer · 91
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
2018 · Giuseppe Bronte, Andrea Rocca, et al. · BMC Cancer · 35
PDF
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations
2014 · D. Amadori, P. Serra, et al. · Breast Cancer Research and Treatment · 34
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology
2016 · Sara Ravaioli, Sara Bravaccini, et al. · Oncotarget · 32
PDF
Gene Mutation Analysis in EGFR Wild Type NSCLC Responsive to Erlotinib: Are There Features to Guide Patient Selection?
2014 · Paola Ulivi, Angelo Delmonte, et al. · International Journal of Molecular Sciences · 31
PDF
miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer
2016 · Samanta Salvi, Chiara Molinari, et al. · OncoTargets and Therapy · 30
PDF
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?
2018 · Giuseppe Bronte, Sara Bravaccini, et al. · Translational Oncology · 29
PDF
ALK translocation detection in non‐small cell lung cancer cytological samples obtained by TBNA or EBUS‐TBNA
2015 · S. Bravaccini, M. M. Tumedei, et al. · Cytopathology · 23
PDF
Benefit from anthracyclines in relation to biological profiles in early breast cancer
2013 · Andrea Rocca, Sara Bravaccini, et al. · Breast Cancer Research and Treatment · 21
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
2019 · Giuseppe Bronte, Andrea Rocca, et al. · Journal of Oncology · 19
PDF
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer
2019 · Manolo D’Arcangelo, Armida D’Incecco, et al. · Oncotarget · 19
PDF
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ
2020 · Alberto Farolfi, Elisabetta Petracci, et al. · Frontiers in Oncology · 17
PDF
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?
2018 · Sara Bravaccini, Sara Ravaioli, et al. · Frontiers in Endocrinology · 17
PDF
Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples
2014 · L. Capelli, C. Marfisi, et al. · Cytopathology · 17
Role of Androgen and Estrogen Receptors as Prognostic and Potential Predictive Markers of Ductal Carcinoma in Situ of the Breast
2015 · Maria Maddalena Tumedei, Rosella Silvestrini, et al. · The International Journal of Biological Markers · 15
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue
2013 · Paola Ulivi, Maurizio Puccetti, et al. · Journal of Clinical Pathology · 15
Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence
2014 · Claudia Rengucci, Giulia De Maio, et al. · Journal of Experimental & Clinical Cancer Research · 14
PDF
Charcoal tattoo localization for differentiated thyroid cancer recurrence in the central compartment of the neck.
2012 · F Soprani, F Bondi, et al. · Europe PMC (PubMed Central) · 14
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations
2022 · Matteo Canale, Elisabetta Petracci, et al. · Translational Oncology · 13
PDF
EGFRandK-rasmutations in cytologic samples from fine-needle aspirates in NSCLC patients: Table 1–
2012 · Paola Ulivi, Wainer Zoli, et al. · European Respiratory Journal · 13
PDF
Spotlight on PSMA as a new theranostic biomarker for bladder cancer
2021 · Maria Maddalena Tumedei, Sara Ravaioli, et al. · Scientific Reports · 12
PDF
The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial
2020 · Sara Bravaccini, Giuseppe Bronte, et al. · Therapeutic Advances in Medical Oncology · 12
PDF
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement
2020 · Giuseppe Bronte, Angelo Delmonte, et al. · Lung Cancer · 11
Preoperative charcoal suspension tattoo for the detection of differentiated thyroid cancer recurrence
2019 · Francesco Soprani, Andrea De Vito, et al. · Molecular and Clinical Oncology · 11
PDF
Works count: 84
Citation count: 876
H-index: 15
I10-index: 30
Year
Topic
Type